| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
inquiry@bocsci.com |
|
| | Ara-C triphosphate Basic information |
| Product Name: | Ara-C triphosphate | | Synonyms: | Ara-C triphosphate;Arabinofuranosylcytosine Triphosphate;Ara-cytidine-5'-triphosphate (ara-CTP) (aqueous solution);ara-Cytidine-5'-triphosphate (ara-CTP);2(1H)-Pyrimidinone, 4-amino-1-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-arabinofuranosyl]-;Cytarabine triphosphate;ara-CTP·Na3;Ara-cytidine-5''-triphosphate (ara-CTP) (aqueous solution), DNA synthesis inhibitor | | CAS: | 13191-15-6 | | MF: | C9H16N3O14P3 | | MW: | 483.16 | | EINECS: | | | Product Categories: | | | Mol File: | 13191-15-6.mol |  |
| | Ara-C triphosphate Chemical Properties |
| Boiling point | 849.2±75.0 °C(Predicted) | | density | 2.50±0.1 g/cm3(Predicted) | | pka | 0.97±0.50(Predicted) | | form | Solid | | color | White to off-white |
| | Ara-C triphosphate Usage And Synthesis |
| Uses | Cytarabine triphosphate (Ara-CTP), an active metabolite of Cytarabine, is a competitive inhibitor of DNA synthesis. Intracellular Cytarabine triphosphate levels can be used to predict chemosensitivity of leukemic blasts to Cytarabine[1]. | | References | [1] Anderson E, et, al. Intracellular cytarabine triphosphate in circulating blasts post-treatment predicts remission status in patients with acute myeloid leukemia. Exp Hematol. 2019 Jun;74:13-18.e3. DOI:10.1016/j.exphem.2019.04.005 |
| | Ara-C triphosphate Preparation Products And Raw materials |
|